Publication | Closed Access
Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
363
Citations
20
References
2012
Year
clinicaltrials.gov Identifier: NCT00810147
| Year | Citations | |
|---|---|---|
Page 1
Page 1